356 related articles for article (PubMed ID: 24554308)
21. Tackling the Biological Meaning of the Human Olfactory Bulb Dyshomeostatic Proteome across Neurological Disorders: An Integrative Bioinformatic Approach.
Cartas-Cejudo P; Lachén-Montes M; Fernández-Irigoyen J; Santamaría E
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768771
[TBL] [Abstract][Full Text] [Related]
22. alpha-Synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells.
Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Argandoña-Palacios L; Garcia-Muñozguren S; Martinez-Marcos A
Acta Neuropathol; 2010 Jun; 119(6):723-35. PubMed ID: 20383714
[TBL] [Abstract][Full Text] [Related]
23. The human olfactory system in two proteinopathies: Alzheimer's and Parkinson's diseases.
Ubeda-Bañon I; Saiz-Sanchez D; Flores-Cuadrado A; Rioja-Corroto E; Gonzalez-Rodriguez M; Villar-Conde S; Astillero-Lopez V; Cabello-de la Rosa JP; Gallardo-Alcañiz MJ; Vaamonde-Gamo J; Relea-Calatayud F; Gonzalez-Lopez L; Mohedano-Moriano A; Rabano A; Martinez-Marcos A
Transl Neurodegener; 2020 Jun; 9(1):22. PubMed ID: 32493457
[TBL] [Abstract][Full Text] [Related]
24. A ventral glomerular deficit in Parkinson's disease revealed by whole olfactory bulb reconstruction.
Zapiec B; Dieriks BV; Tan S; Faull RLM; Mombaerts P; Curtis MA
Brain; 2017 Oct; 140(10):2722-2736. PubMed ID: 28969383
[TBL] [Abstract][Full Text] [Related]
25. Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.
Zelaya MV; Pérez-Valderrama E; de Morentin XM; Tuñon T; Ferrer I; Luquin MR; Fernandez-Irigoyen J; Santamaría E
Oncotarget; 2015 Nov; 6(37):39437-56. PubMed ID: 26517091
[TBL] [Abstract][Full Text] [Related]
26. Potential convergence of olfactory dysfunction in Parkinson's disease and COVID-19: The role of neuroinflammation.
Li H; Qian J; Wang Y; Wang J; Mi X; Qu L; Song N; Xie J
Ageing Res Rev; 2024 Jun; 97():102288. PubMed ID: 38580172
[TBL] [Abstract][Full Text] [Related]
27. Assessment of Olfactory Function in MAPT-Associated Neurodegenerative Disease Reveals Odor-Identification Irreproducibility as a Non-Disease-Specific, General Characteristic of Olfactory Dysfunction.
Markopoulou K; Chase BA; Robowski P; Strongosky A; Narożańska E; Sitek EJ; Berdynski M; Barcikowska M; Baker MC; Rademakers R; Sławek J; Klein C; Hückelheim K; Kasten M; Wszolek ZK
PLoS One; 2016; 11(11):e0165112. PubMed ID: 27855167
[TBL] [Abstract][Full Text] [Related]
28. Olfactory neuropathology in Alzheimer's disease: a sign of ongoing neurodegeneration.
Son G; Jahanshahi A; Yoo SJ; Boonstra JT; Hopkins DA; Steinbusch HWM; Moon C
BMB Rep; 2021 Jun; 54(6):295-304. PubMed ID: 34162463
[TBL] [Abstract][Full Text] [Related]
29. Early olfactory involvement in Alzheimer's disease.
Christen-Zaech S; Kraftsik R; Pillevuit O; Kiraly M; Martins R; Khalili K; Miklossy J
Can J Neurol Sci; 2003 Feb; 30(1):20-5. PubMed ID: 12619779
[TBL] [Abstract][Full Text] [Related]
30. Effect of olfactory bulb pathology on olfactory function in normal aging.
Tremblay C; Serrano GE; Intorcia AJ; Sue LI; Wilson JR; Adler CH; Shill HA; Driver-Dunckley E; Mehta SH; Beach TG
Brain Pathol; 2022 Sep; 32(5):e13075. PubMed ID: 35485279
[TBL] [Abstract][Full Text] [Related]
31. Microglia is associated with p-Tau aggregates in the olfactory bulb of patients with neurodegenerative diseases.
Carmona-Abellan M; Martinez-Valbuena I; Marcilla I; DiCaudo C; Gil I; Nuñez J; Luquin MR
Neurol Sci; 2021 Apr; 42(4):1473-1482. PubMed ID: 32816165
[TBL] [Abstract][Full Text] [Related]
32. Olfaction and Aging: A Mini-Review.
Attems J; Walker L; Jellinger KA
Gerontology; 2015; 61(6):485-90. PubMed ID: 25968962
[TBL] [Abstract][Full Text] [Related]
33. [Olfactory disorders in Alzheimer's disease and in Parkinson's disease. Review of the literature].
Norès JM; Biacabe B; Bonfils P
Ann Med Interne (Paris); 2000 Mar; 151(2):97-106. PubMed ID: 10855362
[TBL] [Abstract][Full Text] [Related]
34. Olfactory deficits induce neurofilament hyperphosphorylation.
Hu J; Wang X; Liu D; Wang Q; Zhu LQ
Neurosci Lett; 2012 Jan; 506(2):180-3. PubMed ID: 22094386
[TBL] [Abstract][Full Text] [Related]
35. Olfactory bulb volume in the clinical assessment of olfactory dysfunction.
Rombaux P; Duprez T; Hummel T
Rhinology; 2009 Mar; 47(1):3-9. PubMed ID: 19382487
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of olfactory dysfunction in aging and neurodegenerative disorders.
Kovács T
Ageing Res Rev; 2004 Apr; 3(2):215-32. PubMed ID: 15177056
[TBL] [Abstract][Full Text] [Related]
37. Neurons, Nose, and Neurodegenerative Diseases: Olfactory Function and Cognitive Impairment.
Fatuzzo I; Niccolini GF; Zoccali F; Cavalcanti L; Bellizzi MG; Riccardi G; de Vincentiis M; Fiore M; Petrella C; Minni A; Barbato C
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768440
[TBL] [Abstract][Full Text] [Related]
38. [Expression of proteins related neurodegeneration in autopsy brains of the aged].
Zhu M; Meng X; Wang L; Hu Y; Zhang H; Han Z
Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):651-6. PubMed ID: 25567589
[TBL] [Abstract][Full Text] [Related]
39. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.
Beach TG; White CL; Hladik CL; Sabbagh MN; Connor DJ; Shill HA; Sue LI; Sasse J; Bachalakuri J; Henry-Watson J; Akiyama H; Adler CH;
Acta Neuropathol; 2009 Feb; 117(2):169-74. PubMed ID: 18982334
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
